Immortals Review: Monthly Prices, Quarterly Commitments and Final-Sale Medicine

At Immortals, the most important number may not be the monthly price displayed beside a medication. The discounted member prices carry an asterisk requiring quarterly billing and a three-month commitment paid upfront. Meanwhile, the medicine pages say membership is not required for treatment. Those statements can coexist, but they describe different purchasing conditions. Before enrolling, a prospective customer needs to distinguish access to care, access to a discount and the amount actually collected at checkout.

This review examines Immortals through its enrollment and contract terms, using public documentation consulted October 19, 2026. The business presents itself as a longevity-focused telehealth platform connecting adults with physicians, not as a service guaranteeing prescriptions. Its catalog includes compounded injectable semaglutide and tirzepatide with glycine and B12, alongside several branded listings. The documentation explains parts of the transaction clearly, particularly physician approval before charging and final-sale medicine purchases. It leaves other consequential details unresolved, including membership cost, named dispensing pharmacies and how general renewal terms apply to individual medication plans.

At a glance

Payment trigger: Immortals says customers are charged only after a physician approves treatment; prescriptions are not guaranteed.
Sources: [6]
Discounted pricing commitment: Displayed member prices require quarterly billing with a three-month commitment paid upfront. The consulted documentation does not establish the membership fee.
Sources: [7] [10]
Medicine refunds: The Immortals Medicine policy makes sales final, with no refunds or returns, while directing customers to contact the business about suspected prescription-filling errors.
Sources: [8]
Renewal notice: General subscription terms require cancellation at least 24 hours before the current period ends to avoid the next subscription charge.
Sources: [9]
Separate testing purchase: Biomarker Tests costs $365 per year and includes two annual rounds of comprehensive blood panels and urine tests plus platform access.
Sources: [11]

Start with the agreement, not the longevity branding

The general terms identify Continuance LLC and its subsidiaries as the operator behind Immortals, Blueprint, Don’t Die and Bryan Johnson brands. The homepage attributes the founding of Immortals and Blueprint to Bryan Johnson and Kate Tolo. That shared identity helps explain the broader longevity positioning, but it does not identify every party involved in a prescription transaction. The consulted documentation does not name the dispensing pharmacies or establish the clinical entity responsible for consultations and prescribing.

Immortals Medicine describes its role as connecting customers with licensed physicians who may prescribe when appropriate. It also presents Carl Seger, M.D., as a board-certified physician specializing in preventive and longevity medicine. Those are provider statements, not independently verified credentials in this review. The distinction matters contractually: the platform’s brand, an individual clinician’s judgment and a pharmacy’s fulfillment duties are separate parts of the service, even when the customer encounters them through one website.

Before accepting the agreement, ask which entity provides medical care, which pharmacy fills the order and which business handles payment disputes. Our guide to mapping platform, clinician and pharmacy responsibilities explains that distinction. Immortals’ public materials establish a physician-review model, but they do not fully allocate responsibility for every problem that could arise between intake, payment and delivery.

Sources: [9] [12] [6]

What the displayed medication prices commit you to

The medication listings show both a subtotal and a lower member order total. The lower figures are monthly equivalents, not evidence of a cancel-anytime monthly purchase: the asterisk specifies quarterly billing and a three-month commitment paid upfront. Membership is advertised as offering up to 15% off medications, but its own price and complete conditions are not established in the consulted documentation. Consequently, the discounted medication figure cannot be treated as the complete cost of participating.

The table preserves the displayed amounts and their product descriptions. Compounded tirzepatide and semaglutide are described as weekly injectables with glycine and B12. Wegovy’s page lists tablets and injections, but the extracted documentation does not unambiguously connect its price to either presentation. Zepbound is specifically listed as KwikPen, while the provider identifies Foundayo as an oral orforglipron tablet. These listings do not settle the precise supply quantity, selected dose or every available variant.

Immortals also repeats a potential annual-savings claim across pages with different monthly discounts, without explaining a product-specific calculation. It is more useful to request a checkout quote than to rely on that repeated figure. The guide to monthly prices and billing commitments offers a framework for checking the actual collection schedule. Here, the unresolved questions include the membership charge and whether the nondiscounted subtotal has different payment terms.

Displayed medication prices; every member figure below requires quarterly billing and a three-month commitment paid upfront. Membership cost is not established.
Provider-listed product	Displayed subtotal	Displayed member price and qualification
Compounded tirzepatide with glycine and B12, weekly injectable	$255/month	$217/month; exact selected dose and supply quantity unresolved
Compounded semaglutide with glycine and B12, weekly injectable	$196/month	$167/month; exact selected dose and supply quantity unresolved
Wegovy, semaglutide; tablets and injections listed	$1,550/month	$1,317/month; presentation associated with price unresolved
Zepbound KwikPen, tirzepatide injection	$600/month	$510/month; exact selected supply unresolved
Foundayo, provider-described oral orforglipron tablet	$750/month	$637/month; exact selected supply unresolved

Sources: [7] [10] [5] [4] [3]

Approval comes before charging, but eligibility comes first

Immortals says there are no insurance requirements and that customers pay only after a physician approves treatment. Its product language also says membership fees are not required to obtain treatment. Those are useful boundaries: completing intake is not a promise of a prescription, and a discount membership should not be confused with mandatory access. However, “no insurance requirements” does not establish insurance acceptance, prior-authorization assistance or coverage for either the consultation or medication.

The intake is advertised as taking five to ten minutes and asks about medical history, current medications, goals and treatment preferences. A physician reviews each case before a prescription is issued. Some states may require a synchronous audio or video consultation before approval. These steps mean enrollment is a clinical assessment process rather than a straightforward retail order, even though the medication pages display shopping-style subtotals and order totals.

Medicine access is advertised for adults 18 and older in eligible U.S. states, with additional medication-specific geographic restrictions. The general terms list services across all 50 states, but that broader list does not establish that every medication is available everywhere. The Personalized Tirzepatide page says it is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2, and that the physician will assess whether treatment is appropriate. The consulted pages do not provide a medication-by-state matrix or the service’s clinical BMI thresholds. A prospective customer should confirm availability for the exact product and state before interpreting a displayed price as an available offer.

Sources: [6] [7] [9]

Cancellation stops future charges, not completed purchases

The general subscription terms provide for automatic renewal until termination. To avoid the next subscription charge, customers must cancel at least 24 hours before the current subscription period ends. Cancellation is available through account settings and becomes effective at the end of the current period. The terms also contemplate applicable taxes and transaction fees. These are general subscription provisions; the consulted documentation does not clearly explain their application to every medicine plan or prescription renewal.

The medicine-specific refund policy is stricter than an ordinary expectation of returning an unused purchase: all Immortals Medicine sales are final, with no refunds or returns. It invites customers to contact the business if they believe an error occurred in filling a prescription. That contact invitation is not a stated refund guarantee. General terms contemplate legal exceptions and discretionary refunds, but customers should not assume those override the specific medicine policy in a routine cancellation.

This makes the order’s status important. Canceling a subscription, preventing a future renewal and reversing an already-paid medicine purchase are different requests. The guide to cancellation notice and renewal dates explains what to document. For Immortals, ask for the next renewal date, the applicable billing period and the treatment of an already-approved or submitted pharmacy order. The public terms do not establish that unused time in a prepaid quarter is refundable.

Sources: [8] [9]

Separate promised timelines from enforceable expectations

Immortals publishes several timing statements that should not be compressed into one delivery promise. The medicine collection says physician review is typically completed within 24 hours. Product pages instead describe review within 72 hours by a physician the business calls U.S.-licensed and board-certified. These are different descriptions, and the consulted documentation does not explain which governs a particular order. Neither statement guarantees that an applicant will receive a prescription.

After review and prescribing, the collection says most medications ship in two to five business days. The tirzepatide page also advertises direct shipment in discreet packaging and a two-to-five-business-day shipping interval. Separately, it describes an overall intake-to-door window of three to seven days. Dispatch and arrival are not interchangeable, and these statements do not establish carrier guarantees, tracking procedures or a remedy if a shipment misses the advertised window.

Follow-up is promoted through unlimited physician messaging, with chat available at any time and video consultations available for up to 12 months. No specific response deadline is stated, and the documentation does not establish whether every video visit, shipping charge, injection supply or required laboratory test is included in each medication price. Before purchasing, ask where billing issues go versus clinical questions, and who handles delayed, damaged or lost packages. Availability of a communication channel is not a defined response-time commitment.

Sources: [6] [7]

Product descriptions do not establish clinical equivalence

Immortals distinguishes its compounded formulations from FDA-approved products, stating that the compounded formularies are not FDA approved and have not been evaluated by FDA for safety, quality or efficacy. It describes sourcing through licensed pharmacies, but the consulted documentation does not name them. The tirzepatide page offers personalized-dose and microdose selections. Those menu choices document how the product is marketed; they do not establish outcomes for the selected formulation, route or amount.

FDA recommends using compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality. That distinction neither proves clinical inequivalence by itself nor validates a particular supplier. FDA approval belongs to a specific product, not to Immortals as a platform or to a dispensing pharmacy.

For a contract decision, the useful question is what exact preparation will be ordered and who will explain its handling and administration. FDA has reported measuring and administration errors involving compounded medication, including some associated with hospitalization. Instructions should be clarified with the prescriber or pharmacist, not reconstructed from a review. FDA also explicitly advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy.

Sources: [7] [6] [1]

Keep biomarker testing and app access separate

Immortals sells a separate Biomarker Tests membership for $365 per year. Its stated inclusions are two comprehensive blood panels and urine tests annually, covering more than 100 unique biomarkers and at least 160 measurements, plus Biomarkers platform access. Initial and follow-up appointments are scheduled through that platform at a local Quest Diagnostics laboratory. This is a separate documented purchase, not evidence that laboratory testing is automatically included in a GLP-1 medication price.

The testing program requires customers to be at least 18 and based in the United States. It currently excludes Arizona, Hawaii, New Jersey, New York and Rhode Island. Its FAQ says 95% of customers receive complete results within two weeks, despite a shorter promotional headline elsewhere. HSA/FSA reimbursement is described as conditional on an eligibility review; eligible customers receive a letter of medical necessity in one to two days to submit with their receipt. This is not guaranteed reimbursement.

The homepage also describes the app and uploading outside biomarker results as free, with panels, prescriptions and supplements optional. However, another homepage phrase labels the app as coming soon, leaving effective availability inconsistent in the consulted documentation. The general terms warn that AI tools do not provide medical advice and may be inaccurate. Free digital access, a testing subscription and physician-supervised medication should therefore be treated as distinct offerings rather than assumed components of one paid care package.

Sources: [11] [12] [9]

Get the unresolved conditions in writing

A useful written quote should identify the exact medicine, formulation, route, presentation, selected supply and collection schedule. For Immortals, it should also separate the medication subtotal, member discount, membership fee, taxes and any transaction charges. Ask whether consultations, video visits, laboratory work, injection materials and shipping are included or billed separately. Our guide to requesting a written GLP-1 quote helps organize these details without assuming that every listed product has identical conditions.

The same confirmation should identify the clinical practice and dispensing pharmacy, describe the support channel for fulfillment errors and state what happens at renewal. A three-month payment commitment does not by itself establish the quantity supplied or how prescription reassessment works. Nor does the advertised support period prove a price lock. The missing detail is not evidence that Immortals lacks a process; it means the public documentation reviewed here is insufficient to describe that process reliably.

Finally, distinguish payment continuity from clinical continuity. NIDDK describes medication selection as a discussion of benefits, side effects, other medicines, health conditions and cost, with follow-up addressing tolerance and response. An automatically renewing payment does not answer those clinical questions. For this provider, a practical enrollment decision depends on whether the written checkout and care terms resolve the gaps between its clear physician-approval promise, its quarterly member pricing and its restrictive medicine refund policy.

Sources: [7] [6] [8] [9] [2]

Questions & answers

Do I have to buy an Immortals membership to receive medication?

The medicine pages say membership fees are not required for treatment. However, the lower displayed order totals are member prices, and those figures require quarterly billing with a three-month commitment paid upfront. The consulted documentation does not establish the membership fee or complete membership conditions. Ask for both the nonmember checkout terms and the full member cost rather than comparing medication figures alone.

Sources: [7] [10]

Will Immortals charge me if the physician does not approve treatment?

Immortals says customers are charged only after physician approval and that prescriptions are not guaranteed. Intake is the first assessment step, not approval to purchase any listed medicine. The public pages do not fully explain every checkout authorization or order-processing step, so customers wanting more detail should request the precise payment trigger and ask how a declined application is reflected in their account.

Sources: [6]

Can I cancel and get the unused portion of a medication payment back?

The documentation does not promise that result. General terms say account-setting cancellation stops future charges and takes effect at the end of the current subscription period. The medicine policy separately states that sales are final, without refunds or returns. Cancel at least 24 hours before the period ends to avoid the next subscription charge, and obtain confirmation of how those general rules apply to your specific medication plan.

Sources: [9] [8]

Does the Wegovy price apply to tablets or injections?

The consulted product text does not resolve that. It lists both tablets and injections, alongside a $1,550 monthly subtotal and a $1,317 monthly member figure. The member figure requires quarterly billing and a three-month commitment paid upfront. Before purchasing, request confirmation of the precise presentation, dose, supply quantity and applicable price. The two listed presentations should not be assumed to have identical checkout terms.

Sources: [5]

Who should I contact about a prescription-filling error?

The medicine refund policy directs customers to contact Immortals if they suspect an error in filling a prescription, but it does not promise a particular remedy. The consulted documentation does not name the dispensing pharmacies or fully describe an escalation process. Request the pharmacy’s contact information and Immortals’ support route before ordering. A clinical question, a fulfillment error and a disputed charge may require different responsible parties.

Sources: [8] [6]

Is the $365 biomarker subscription part of GLP-1 treatment?

It is documented as a separate subscription, not a confirmed inclusion in medication pricing. It provides two annual rounds of blood panels and urine tests with platform access, using Quest Diagnostics appointments. Eligibility and state restrictions differ from the medicine program. Its conditional HSA/FSA reimbursement pathway also should not be treated as evidence that GLP-1 medication purchases qualify for reimbursement or that either service has insurance coverage.

Sources: [11]

Our assessment

Immortals documents several meaningful consumer boundaries: physician review before prescribing, charging only after approval, no mandatory membership for treatment and a clear medicine-specific final-sale policy. Its medication catalog and separate biomarker offering are also described in useful detail. The weaker point is the complete transaction: discounted monthly figures require prepaid quarterly commitments, while membership cost, exact supply, named care partners and several included-service questions remain unresolved. General renewal terms provide a cancellation mechanism but do not clearly map every medication plan. For an adult considering enrollment, the decisive document is therefore a written, product-specific checkout agreement that reconciles the advertised price with membership, renewal, fulfillment and refund conditions. The public materials support further evaluation of the service, but not an assumption of simple month-to-month purchasing or refundable unused treatment.

Visit Immortals’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Immortals Review: Monthly Prices, Quarterly Commitments and Final-Sale Medicine

At a glance

01Start with the agreement, not the longevity branding

02What the displayed medication prices commit you to

03Approval comes before charging, but eligibility comes first

04Cancellation stops future charges, not completed purchases

05Separate promised timelines from enforceable expectations

06Product descriptions do not establish clinical equivalence

07Keep biomarker testing and app access separate

08Get the unresolved conditions in writing